Browsing Category

44716 posts
Thai Scientists from Chula to Investigate Global Warming in Antarctica

Thai Scientists from Chula to Investigate Global Warming in Antarctica

BANGKOK, March 10, 2025 /PRNewswire/ — Prof. Dr. Suchana Chavanich from the Department…
HASHKEY GLOBAL PARTNERS WITH VERIFYVASP TO EXPAND GLOBAL TRAVEL RULE COMPLIANCE

HASHKEY GLOBAL PARTNERS WITH VERIFYVASP TO EXPAND GLOBAL TRAVEL RULE COMPLIANCE

Strategic partnership strengthens regulatory compliance across HashKey Global’s international exchange network. SINGAPORE,…
Webull Singapore launches trading competition for Singapore traders

Webull Singapore launches trading competition for Singapore traders

SINGAPORE, March 10, 2025 /PRNewswire/ — Webull Securities (Singapore) Pte Ltd ("Webull Singapore"), a…

RiboX Therapeutics Announces First Patient Dosed in Phase I/IIa Clinical Trial of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation

PRINCETON, N.J., March 10, 2025 /PRNewswire/ — RiboX Therapeutics Ltd. (RiboX), a pioneering…
China Telecom and Partners Innovate Together! 5G UAV Medical Delivery Network Wins Global Mobile Award

China Telecom and Partners Innovate Together! 5G UAV Medical Delivery Network Wins Global Mobile Award

HONG KONG, March 10, 2025 /PRNewswire/ — On March 5, during the…

AIM Vaccine's Iteratively Upgraded Diploid Rabies Vaccine Approved for Clinical Trials, Showing Significantly Higher Efficacy than Marketed Diploid Rabies Vaccines

HONG KONG, March 10, 2025 /PRNewswire/ — AIM Vaccine Co., Ltd. (06660.HK),…
U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®

U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the…
Appian Unveils Latest Platform Release for Faster, More Powerful Data Fabric and AI Experience

Appian Unveils Latest Platform Release for Faster, More Powerful Data Fabric and AI Experience

SYDNEY, March 10, 2025 /PRNewswire/ — Appian (NASDAQ: APPN) today announced the…